Foundayo was approved in the U.S. on April 1, with prescriptions accepted immediately on LillyDirect, while shipping started ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

A recent FDA approval means consumers now have two GLP-1 weight loss pills to choose from as an alternative to the ...

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills ...

Eli Lilly just released results of a clinical trial that may ease concerns about the safety of its new weight-loss pill ...

The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new ...

Glucagon-like peptide-1 (GLP-1) medications are now available as a pill for weight loss, offering another option beyond injections. Like the injections, GLP-1 pills can help regulate your appetite, ...

People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, constipation, or diarrhea.

Popular weight loss drugs reached a new era this year when they became available in the form of a pill. Now U.S. consumers ...

For decades, researchers have been looking for an effective weight-loss pill. But the recent success of glucagon-like peptide-1 (GLP-1) weight-loss injections has sparked new hope — especially for ...